Suggestions
Philip Oettinger
Partner at Wilson Sonsini Goodrich and Rosati
Professional Background
Philip Oettinger is an esteemed legal professional whose career has been dedicated to providing exceptional corporate legal services to emerging growth companies, particularly within the life sciences sector. His multifaceted expertise as a corporate attorney at prominent firms along with his experience in the federal government equips him with the knowledge and insight necessary to guide his clients through the complex landscape of corporate law. As a trusted general counsel, Philip serves clients who either cannot afford in-house legal teams or prefer outside counsel. His focus primarily lies in supporting companies that are at the forefront of innovation in fields such as medical devices, digital health, diagnostics, and biotechnology.
In his role, Philip ensures that his clients benefit from continuity of representation. He is deeply involved in various aspects of corporate life, from company formations and equity as well as debt financings to mergers and acquisitions, and initial public offerings. His hands-on approach means that clients receive dedicated support and guidance throughout their entire company lifecycle. Beyond transactional legal matters, he frequently advises boards of directors and company management, providing them with practical business advice aimed at navigating challenges and driving success.
Education and Achievements
Philip Oettinger has a solid educational background that forms the foundation of his legal expertise. He earned a Bachelor of Science in Urban Studies from the prestigious Cornell University, a program that honed his analytical and strategic thinking skills. He then went on to pursue a Juris Doctor (J.D.) from American University’s Washington College of Law, where he developed a thorough understanding of the legal frameworks that govern corporate practices.
In terms of professional experience, Philip has held significant positions such as Partner at Wilson Sonsini Goodrich & Rosati, a leading law firm known for its commitment to serving innovative and technology-driven businesses. In addition to his role as a partner, he has also previously served as an attorney at the U.S. Securities and Exchange Commission (SEC). At the SEC, he gained invaluable insights into both federal and state securities laws and regulations, which are essential for legal compliance and corporate governance in the life sciences sector.
Achievements
Throughout his career, Philip has established himself as a vital asset to his clients in the life sciences industry. His extensive knowledge of the intricacies of medical device regulations, digital health initiatives, diagnostics, and biotechnological advancements positions him as a formidable advocate for his clients. Philip’s commitment to improving patient care through legal counsel truly underscores his passion for making a difference in the industry. He thrives on the challenges faced by growth companies and leverages his experience in the legal domain to craft solutions tailored to the specific needs of each client.
Philip’s contributions to the legal community and his clients have not gone unnoticed. His understanding of the business and regulatory landscape surrounding life sciences enables him to effectively identify potential legal hurdles and mitigate risks associated with company operation and growth. His dedication to excellence and persistence in addressing client concerns has earned him a reputation as a reliable and resourceful lawyer, making him a sought-after general counsel in the field.
With a comprehensive focus on both legal and practical business frameworks, Philip Oettinger stands out as an outstanding attorney ready to meet the challenges of the life sciences industry head-on. His clients value his proactive approach and the ongoing relationships they foster, which ultimately foster a collaborative atmosphere aimed at achieving common goals. In a field where continual innovation is paramount, having a legal expert like Philip provides companies with the confidence to navigate complex regulatory environments and focus on their mission of enhancing patient care and health outcomes.